Search research articles
Contact Us
Filters
Showing results (11-20 of 109) with videos related to
Page
of 11
Sort By:
Frontiers in Oncology
|
December 24, 2013
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
Clare L Scott, Marc A Becker, Paul Haluska, et al.
Nature Reviews. Cancer
|
April 4, 2009
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Mark S Cragg, Claire Harris, Andreas Strasser, et al.
Therapeutic Advances in Medical Oncology
|
October 1, 2025
Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine
Holly E Barker, Joseph Polidano, Andrew Jarratt, et al.
Asia-Pacific Journal of Clinical Oncology
|
September 3, 2011
The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions
Fiona Chionh, Gillian Mitchell, Geoffrey J Lindeman, et al.
The Journal of Pathology
|
December 29, 2017
Targeting DNA repair: the genome as a potential biomarker
Ksenija Nesic, Matthew Wakefield, Olga Kondrashova, et al.
Neuropsychologia
|
October 5, 2007
Longitudinal aspects of emotion recognition in patients with traumatic brain injury
Magdalena Ietswaart, Maarten Milders, John R Crawford, et al.
Molecular Imaging and Biology
|
May 25, 2005
The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin
Clare L Scott, Iveta Kudaba, Josephine M Stewart, et al.
Journal of Geriatric Oncology
|
July 10, 2025
Real-world ovarian cancer care and its survival impact on older adults: An observational study from the Australian National Gynae-Oncology Registry (NGOR)
Mahendra Naidoo, Clare L Scott, Orla McNally, et al.
BMC Neurology
|
July 19, 2012
Emotion processing and social participation following stroke: study protocol
Clare L Scott, Louise H Phillips, Marie Johnston, et al.
Frontiers in Genetics
|
September 26, 2022
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
Nirashaa T Bound, Cassandra J Vandenberg, Apriliana E R Kartikasari, et al.
Page
of 11
Search research articles
Search
Showing results (11-20 of 109) with videos related to
Sort By:
Page
of 11
Frontiers in Oncology
|
December 24, 2013
Patient-derived xenograft models to improve targeted therapy in epithelial ovarian cancer treatment
Clare L Scott, Marc A Becker, Paul Haluska, et al.
Nature Reviews. Cancer
|
April 4, 2009
Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics
Mark S Cragg, Claire Harris, Andreas Strasser, et al.
Therapeutic Advances in Medical Oncology
|
October 1, 2025
Genomics of cervical, vulvar and vaginal cancers and the potential of precision medicine
Holly E Barker, Joseph Polidano, Andrew Jarratt, et al.
Asia-Pacific Journal of Clinical Oncology
|
September 3, 2011
The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions
Fiona Chionh, Gillian Mitchell, Geoffrey J Lindeman, et al.
The Journal of Pathology
|
December 29, 2017
Targeting DNA repair: the genome as a potential biomarker
Ksenija Nesic, Matthew Wakefield, Olga Kondrashova, et al.
Neuropsychologia
|
October 5, 2007
Longitudinal aspects of emotion recognition in patients with traumatic brain injury
Magdalena Ietswaart, Maarten Milders, John R Crawford, et al.
Molecular Imaging and Biology
|
May 25, 2005
The utility of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography in the investigation of patients with disseminated carcinoma of unknown primary origin
Clare L Scott, Iveta Kudaba, Josephine M Stewart, et al.
Journal of Geriatric Oncology
|
July 10, 2025
Real-world ovarian cancer care and its survival impact on older adults: An observational study from the Australian National Gynae-Oncology Registry (NGOR)
Mahendra Naidoo, Clare L Scott, Orla McNally, et al.
BMC Neurology
|
July 19, 2012
Emotion processing and social participation following stroke: study protocol
Clare L Scott, Louise H Phillips, Marie Johnston, et al.
Frontiers in Genetics
|
September 26, 2022
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
Nirashaa T Bound, Cassandra J Vandenberg, Apriliana E R Kartikasari, et al.
Page
of 11